- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Kleve, Hochschule Rhein-Waal, Bachelorarbeit, 2023
- Event
-
Veröffentlichung
- (where)
-
Kleve
- (who)
-
Hochschule Rhein-Waal
- (when)
-
2023
- Creator
-
Belkhodja, Fatma
- Contributor
-
Böhmer, Christoph
Palmada Fenés, Monica
- URN
-
urn:nbn:de:hbz:1383-opus4-18504
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:51 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Belkhodja, Fatma
- Böhmer, Christoph
- Palmada Fenés, Monica
- Hochschule Rhein-Waal
Time of origin
- 2023
Other Objects (12)
Novel strategies to overcome chemoresistance in glioblastoma
Transferrin Receptor-Targeted Nonspherical Microbubbles for Blood–Brain Barrier Sonopermeation
Tumor Treating Fields (TTFields) reversibly permeabilize the blood–brain barrier in vitro and in vivo
Toxicity of poly(n-butylcyano-acrylate) (PBCA)-nanoparticles designed to overcome the blood-brain barrier
First report of tumor treating fields (TTFields) therapy for glioblastoma in comorbidity with multiple sclerosis
Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
Targeted delivery of tyrosine kinase inhibitors across the blood-brain barrier with functionalized liposomal nanocarriers
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Tumor Treating Fields (TTFields) induce cell junction alterations in a human 3D in vitro model of the blood-brain barrier
Glioblastoma-derived three-dimensional ex vivo models to evaluate effects and efficacy of Tumor Treating Fields (TTFields)
In vivo evaluation of polymeric nanocarriers for targeted gene delivery and novel strategies to overcome chemoresistance
Computational drug design based in natural leads to overcome drug resistance in targeted and pan-cancer therapy
Novel strategies to overcome chemoresistance in glioblastoma
Transferrin Receptor-Targeted Nonspherical Microbubbles for Blood–Brain Barrier Sonopermeation
Tumor Treating Fields (TTFields) reversibly permeabilize the blood–brain barrier in vitro and in vivo
Toxicity of poly(n-butylcyano-acrylate) (PBCA)-nanoparticles designed to overcome the blood-brain barrier
First report of tumor treating fields (TTFields) therapy for glioblastoma in comorbidity with multiple sclerosis
Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
Targeted delivery of tyrosine kinase inhibitors across the blood-brain barrier with functionalized liposomal nanocarriers
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Tumor Treating Fields (TTFields) induce cell junction alterations in a human 3D in vitro model of the blood-brain barrier
Glioblastoma-derived three-dimensional ex vivo models to evaluate effects and efficacy of Tumor Treating Fields (TTFields)
In vivo evaluation of polymeric nanocarriers for targeted gene delivery and novel strategies to overcome chemoresistance
Computational drug design based in natural leads to overcome drug resistance in targeted and pan-cancer therapy
Novel strategies to overcome chemoresistance in glioblastoma
Transferrin Receptor-Targeted Nonspherical Microbubbles for Blood–Brain Barrier Sonopermeation
Tumor Treating Fields (TTFields) reversibly permeabilize the blood–brain barrier in vitro and in vivo
Toxicity of poly(n-butylcyano-acrylate) (PBCA)-nanoparticles designed to overcome the blood-brain barrier
First report of tumor treating fields (TTFields) therapy for glioblastoma in comorbidity with multiple sclerosis
Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition
Targeted delivery of tyrosine kinase inhibitors across the blood-brain barrier with functionalized liposomal nanocarriers
Molecular profiling-based decision for targeted therapies in IDH wild-type glioblastoma
Tumor Treating Fields (TTFields) induce cell junction alterations in a human 3D in vitro model of the blood-brain barrier
Glioblastoma-derived three-dimensional ex vivo models to evaluate effects and efficacy of Tumor Treating Fields (TTFields)
In vivo evaluation of polymeric nanocarriers for targeted gene delivery and novel strategies to overcome chemoresistance